SMTL ID : 7c7f.2 (1 other biounit)

Crystal structures of AKR1C3 binary complex with NADP+

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.70 Å

Oligo State

monomer

Ligands

1 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NAP.1: 29 residues within 4Å: Chain A: G.24, T.25, Y.26, D.52, Y.57, K.86, H.119, S.168, N.169, Q.192, Y.218, S.219, A.220, L.221, G.222, S.223, Q.224, L.238, A.255, L.270, A.271, K.272, S.273, Y.274, R.278, Q.281, N.282, F.308 Ligands: ACT.4 24 PLIP interactions: 24 interactions with chain A Hydrophobic interactions: A:F.308 Hydrogen bonds: A:T.25, A:Y.26, A:D.52, A:D.52, A:Y.57, A:S.168, A:N.169, A:Q.192, A:S.219, A:L.221, A:S.223, A:Q.224, A:K.272, A:S.273, A:Y.274, A:Q.281, A:N.282 Water bridges: A:A.220, A:R.278, A:R.278 Salt bridges: A:K.272, A:R.278 pi-Stacking: A:Y.218

2 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.2: 6 residues within 4Å: Chain A: F.17, P.19, E.79, I.81, F.82, D.114 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:I.81 Water bridges: A:F.17 EDO.3: 9 residues within 4Å: Chain A: Q.8, P.19, V.20, L.21, G.47, F.48, R.49, H.50, F.286 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:Q.8, A:V.20, A:L.21, A:G.47, A:R.49, A:H.50

1 x ACT: ACETATE ION(Non-functional Binders)

ACT.4: 4 residues within 4Å: Chain A: L.56, Y.57, H.119 Ligands: NAP.1 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:L.56 Salt bridges: A:H.119

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Endo, S. et al., Development of Novel AKR1C3 Inhibitors as New Potential Treatment for Castration-Resistant Prostate Cancer. J.Med.Chem. (2020)

Release Date

2020-09-23

Peptides

Aldo-keto reductase family 1 member C3: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Aldo-keto reductase family 1 member C3

Related Entries With Identical Sequence